UBS cuts Ally Financial target price to $48 from $50
ALLY•UBS cut its target price for Ally Financial to $48 from $50.
Related News
Roche receives FDA 510(k) clearance for new cobas eplex Respiratory Pathogen Panel 3
RHHBY•
U.S. Bancorp subsidiary U.S. Bank reports $22.36 billion in nine-month total interest income
USB•
FactSet and Hamilton Lane announce strategic partnership for private markets analytics
FDS•
PerkinElmer appoints Dr. Kaveh Kahen as president of analytical and testing solutions business
RVTY•
Dr. Reddy's wins tentative FDA approval for twice-yearly HIV prevention injection
RDY•